ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,593, issued on May 20, was assigned to Breath Therapeutics GmbH (Munich).
"Inhalable compositions comprising macrocyclic immunosuppressants" was invented by Oliver Denk (Muensing, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition comprising an inhalable immunosuppressive macrocyclic active ingredient for use in the prevention or treatment of a pulmonary disease or condition in a subject, wherein the pharmaceutical composition is administered to the subject by inhalation in form of an aerosol, and wherein the aerosol is generated by nebulization of the pharmaceutical composition usin...